Davenport, Miles P.

What level of neutralising antibody protects from COVID-19?

Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 3,742

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 3,742

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,333

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 873

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis

Cromer, D., Steain, M., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Kent, S. J., Triccas, J. A., Khoury, D. S., & Davenport, M. P. (2022) · The Lancet Microbe

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 590

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell Immunology

Cited by 437

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Wheatley, A. K., Juno, J. A., Wang, J. J., Selva, K. J., Reynaldi, A., Tan, H.-X., Lee, W. S., Wragg, K. M., Kelly, H. G., Esterbauer, R., et al. (2021) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 351

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 265

Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine

Goel, R. R., Painter, M. M., Lundgreen, K. A., Apostolidis, S. A., Baxter, A. E., Giles, J. R., Mathew, D., Pattekar, A., Reynaldi, A., Khoury, D. S., et al. (2022) · Cell

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 207

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

Kent, S. J., Khoury, D. S., Reynaldi, A., Juno, J. A., Wheatley, A. K., Stadler, E., John Wherry, E., Triccas, J., Sasson, S. C., Cromer, D., et al. (2022) · Nature Reviews Immunology

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 139

Neutralising antibodies predict protection from severe COVID-19

Cromer, D., Steain, M., Reynaldi, A., Schlub, T. E., Sasson, S. C., Kent, S. J., Khoury, D. S., & Davenport, M. P. (2022) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 139

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models

Khoury, D. S., Wheatley, A. K., Ramuta, M. D., Reynaldi, A., Cromer, D., Subbarao, K., O’Connor, D. H., Kent, S. J., & Davenport, M. P. (2020) · Nature Reviews Immunology

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 115

Kinetics of Virus-Specific CD8+T Cells and the Control of Human Immunodeficiency Virus Infection

Davenport, M. P., Ribeiro, R. M., & Perelson, A. S. (2004) · Journal of Virology

HIV Research and TreatmentT-cell and B-cell Immunology

Cited by 101

Decay of Fc-dependent antibody functions after mild to moderate COVID-19

Lee, W. S., Selva, K. J., Davis, S. K., Wines, B. D., Reynaldi, A., Esterbauer, R., Kelly, H. G., Haycroft, E. R., Tan, H.-X., Juno, J. A., et al. (2020) · Cell Reports Medicine

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 80

Accurately Measuring Recombination between Closely Related HIV-1 Genomes

Schlub, T. E., Smyth, R. P., Grimm, A. J., Mak, J., & Davenport, M. P. (2010) · PLoS Computational Biology

HIV Research and TreatmentEvolution and Genetic Dynamics

Cited by 64

The gene regulatory basis of bystander activation in CD8 + T cells

Watson, N. B., Patel, R. K., Kean, C., Veazey, J., Oyesola, O. O., Laniewski, N., Grenier, J. K., Wang, J., Tabilas, C., Yee Mon, K. J., et al. (2024) · Science Immunology

T-cell and B-cell ImmunologyGenomics and Chromatin Dynamics

Cited by 46

Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial

Cromer, D., Reynaldi, A., Steain, M., Triccas, J. A., Davenport, M. P., & Khoury, D. S. (2022) · Clinical Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 23

High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection

Claiborne, D. T., Detwiler, Z., Docken, S. S., Borland, T. D., Cromer, D., Simkhovich, A., Ophinni, Y., Okawa, K., Bateson, T., Chen, T., et al. (2025) · Nature Communications

CRISPR and Genetic EngineeringHIV Research and Treatment

Cited by 16